Latest News & Features
Big Pharma
The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement. 12 July 2017
Big Pharma
The Italian Patent and Trademark Office’s Board of Appeal has ruled that there are no rules preventing the office from adjudicating requests to limit the term of supplementary protection certificates. 12 July 2017
Biotechnology
The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process. 11 July 2017
Americas
The Broad Institute of MIT and Harvard has announced that it has entered talks to create a worldwide licensing pool for CRISPR/Cas9 patents. 11 July 2017
Big Pharma
The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions. 7 July 2017
Europe
Biotech company Silence Therapeutics has filed a case on supplementary protection certificates at the English Patents Court against Alnylam and The Medicines Company. 7 July 2017
Big Pharma
The European Commission has sent statements of objections to Merck and Sigma-Aldrich, stating that it has concerns regarding their merger in 2015. 6 July 2017
Biotechnology
More than 120 tons of counterfeit pesticides have been seized during an operation by Europol. 6 July 2017
Big Pharma
GSK has entered into a strategic drug discovery collaboration with an artificial intelligence-driven drug discovery company, Exscientia. 5 July 2017
Americas
Medical device company OrthoAccel Technologies has filed a complaint against Propel Orthodontics for patent infringement. 5 July 2017